Molecular Partners released positive Phase 1/2a trial data for MP0533, a tetraspecific T-cell engager targeting relapsed/refractory acute myeloid leukemia...

PolyPid Ltd. announced positive topline results from its Phase 3 SHIELD II trial of D-PLEX100, demonstrating a statistically significant...

PolyPid Ltd. announced positive topline results from its Phase 3 SHIELD II trial, showing D-PLEX100 significantly reduced surgical site...

Celldex released 76-week data from a Phase 2 trial of barzolvolimab for chronic spontaneous urticaria (CSU). Seven months after...

Syndax Pharmaceuticals announced positive results from the BEAT AML trial of revumenib combined with venetoclax and azacitidine (ven/aza) in...

Apex Labs Ltd. received approval from Israel’s Ministry of Health to expand its phase 2b clinical trial, SUMMIT-90, for...

Spark Biomedical concluded enrollment for its pivotal clinical trial using transcutaneous auricular neurostimulation (tAN) to improve treatment retention for...

At the 2025 Veeva R&D and Quality Summit Europe, Martin Helling, Executive Director of the One Medicine Platform at...

Artificial intelligence (AI) is reshaping clinical trials, offering new efficiencies and insights. Rohit Nambisan, CEO of Lokavant, shares his...

Atai Life Sciences and Beckley Psytech are merging in an all-stock transaction, creating atai Beckley, a leading mental health...